ExLibris header image
SFX logo
Contains information about title and source of a journal
Title: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
Source:

JAMA: the Journal of the American Medical Association [0098-7484] Fisher, C J yr:1994 vol:271 iss:23 pg:1836 -1843

Contains list of services for current record

Full Text

service type icon, opens target in new window

Holding information

service type icon, opens target in new window

ILL

service type icon, opens target in new window

Download Citation

service type icon, opens target in new window

Contact Us

service type icon, opens target in new window
service type icon, opens target in new window
service type icon, opens target in new window


© 2017 SFX by Ex Libris Inc.
CrossRef Enabled